These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2541126)

  • 21. Carbovir: the (-) enantiomer is a potent and selective antiviral agent against human immunodeficiency virus in vitro.
    Coates JA; Inggall HJ; Pearson BA; Penn CR; Storer R; Williamson C; Cameron JM
    Antiviral Res; 1991 Feb; 15(2):161-8. PubMed ID: 1677557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of anti-human immunodeficiency virus 2',3'-dideoxynucleoside monophosphates from DNA by a novel human cytosolic 3'-->5' exonuclease.
    Skalski V; Liu SH; Cheng YC
    Biochem Pharmacol; 1995 Sep; 50(6):815-21. PubMed ID: 7575643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. 1. Stability studies for hairless rat skin permeation.
    Kim DD; Chien YW
    J Pharm Sci; 1995 Sep; 84(9):1061-6. PubMed ID: 8537882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2',3'-dideoxycytidine.
    Zeidner NS; Strobel JD; Perigo NA; Hill DL; Mullins JI; Hoover EA
    Antiviral Res; 1989 Apr; 11(3):147-60. PubMed ID: 2544137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus.
    Inoue T; Tsushita K; Itoh T; Ogura M; Hotta T; Saneyoshi M; Yoshida S; Saitoh H; Tomoda Y; Nagai Y
    Antimicrob Agents Chemother; 1989 Apr; 33(4):576-9. PubMed ID: 2543285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3'-Carbon-substituted pyrimidine nucleosides having a 2',3'-dideoxy and 2',3'-didehydro-2',3'-dideoxy structure: synthesis and antiviral evaluation.
    Kumamoto H; Onuma S; Tanaka H; Dutschman GE; Cheng YC
    Antivir Chem Chemother; 2006; 17(4):225-34. PubMed ID: 17066900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(12):363-7. PubMed ID: 1353278
    [No Abstract]   [Full Text] [Related]  

  • 28. Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro.
    Vince R; Hua M; Brownell J; Daluge S; Lee FC; Shannon WM; Lavelle GC; Qualls J; Weislow OS; Kiser R
    Biochem Biophys Res Commun; 1988 Oct; 156(2):1046-53. PubMed ID: 2847711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans.
    Dornsife RE; Averett DR
    Antimicrob Agents Chemother; 1996 Feb; 40(2):514-9. PubMed ID: 8834914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Suppression of the human immunodeficiency virus in cultured cells by 5'-phosphites of 3'-azido-2',3'-dideoxynucleosides].
    Karamov EV; Lukashov VV; Tarusova NB; Kornilaeva GV; Rodova MA; Kukhanova MK; Kraevskiĭ AA
    Mol Biol (Mosk); 1990; 24(6):1695-701. PubMed ID: 1710021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
    Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
    Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxandrolone, used for treatment of wasting disease in HIV-1-infected patients, does not diminish the antiviral activity of deoxynucleoside analogues in lymphocyte and macrophage cell cultures.
    Segal DM; Perez M; Shapshak P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):215-9. PubMed ID: 10077168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of lymphomas during ddC or ddC/zidovudine combination therapy in persons infected with HIV type 1.
    Moyle GJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):464-5. PubMed ID: 8970476
    [No Abstract]   [Full Text] [Related]  

  • 34. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
    Matthews SJ; Cersosimo RJ; Spivack ML
    Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zalcitabine.
    Shelton MJ; O'Donnell AM; Morse GD
    Ann Pharmacother; 1993 Apr; 27(4):480-9. PubMed ID: 8097417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enantiomeric 2',3'-dideoxycytidine derivatives are potent human immunodeficiency virus inhibitors in cell cultures.
    Gosselin G; Mathé C; Bergogne MC; Aubertin AM; Kirn A; Schinazi RF; Sommadossi JP; Imbach JL
    C R Acad Sci III; 1994 Jan; 317(1):85-9. PubMed ID: 7987696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro anti-human immunodeficiency virus activity of 2',3'-dideoxynucleosides and their effect on clonal growth of hemopoietic cells from human bone marrow.
    Cinatl J; Cinatl J; Rabenau H; Gümbel H; Doerr HW
    Arzneimittelforschung; 1993 May; 43(5):622-5. PubMed ID: 8329011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental pharmacology and toxicology of anti-HIV therapeutic agents: dideoxynucleosides.
    Sandberg JA; Slikker W
    FASEB J; 1995 Sep; 9(12):1157-63. PubMed ID: 7672508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages.
    Szebeni J; Wahl SM; Popovic M; Wahl LM; Gartner S; Fine RL; Skaleric U; Friedmann RM; Weinstein JN
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3842-6. PubMed ID: 2542948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent, alternating, and concurrent regimens of zidovudine and 2'-3' dideoxycytidine in the LP-BM5 murine induced immunodeficiency model.
    Basham T; Holdener T; Merigan T
    J Infect Dis; 1991 Apr; 163(4):869-72. PubMed ID: 1849164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.